M. Feigen

980 total citations
29 papers, 676 citations indexed

About

M. Feigen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, M. Feigen has authored 29 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 7 papers in Surgery. Recurrent topics in M. Feigen's work include Pleural and Pulmonary Diseases (6 papers), Occupational and environmental lung diseases (6 papers) and Medical Imaging and Pathology Studies (6 papers). M. Feigen is often cited by papers focused on Pleural and Pulmonary Diseases (6 papers), Occupational and environmental lung diseases (6 papers) and Medical Imaging and Pathology Studies (6 papers). M. Feigen collaborates with scholars based in Australia, United Kingdom and United States. M. Feigen's co-authors include Andrew M. Scott, George Quong, Salvatore U. Berlangieri, Simon Knight, Michael Boyer, Steven Leong, Christopher Clarke, Jocelyn McLean, Arthur W. Musk and Penelope Schofield and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

M. Feigen

29 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Feigen Australia 14 485 229 157 149 100 29 676
A.T. Porter United States 12 300 0.6× 250 1.1× 97 0.6× 122 0.8× 235 2.4× 22 549
Lawrence R. Coia United States 7 203 0.4× 119 0.5× 131 0.8× 229 1.5× 78 0.8× 8 432
Steve Kelly United Kingdom 7 252 0.5× 142 0.6× 232 1.5× 115 0.8× 78 0.8× 12 499
Kovač Slovenia 4 544 1.1× 158 0.7× 199 1.3× 57 0.4× 91 0.9× 7 613
A. Rahn Germany 12 173 0.4× 202 0.9× 119 0.8× 75 0.5× 226 2.3× 22 432
Irina Rachinsky Canada 13 220 0.5× 167 0.7× 57 0.4× 140 0.9× 46 0.5× 39 532
Ruth Peter United States 8 444 0.9× 185 0.8× 105 0.7× 111 0.7× 338 3.4× 11 629
Adrian Wong United States 11 258 0.5× 153 0.7× 294 1.9× 325 2.2× 194 1.9× 15 642
Justin Rineer United States 15 380 0.8× 151 0.7× 188 1.2× 192 1.3× 167 1.7× 37 648
Hendrik Dapper Germany 12 238 0.5× 247 1.1× 101 0.6× 125 0.8× 61 0.6× 33 437

Countries citing papers authored by M. Feigen

Since Specialization
Citations

This map shows the geographic impact of M. Feigen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Feigen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Feigen more than expected).

Fields of papers citing papers by M. Feigen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Feigen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Feigen. The network helps show where M. Feigen may publish in the future.

Co-authorship network of co-authors of M. Feigen

This figure shows the co-authorship network connecting the top 25 collaborators of M. Feigen. A scholar is included among the top collaborators of M. Feigen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Feigen. M. Feigen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Armato, Samuel G., Zacariah E. Labby, Johan Coolen, et al.. (2013). Imaging in pleural mesothelioma: A review of the 11th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 82(2). 190–196. 27 indexed citations
2.
Feigen, M., et al.. (2011). Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and 18F-FDG PET/CT scan correlation. Journal of Medical Imaging and Radiation Oncology. 55(3). 320–332. 22 indexed citations
3.
Joon, Daryl Lim, Michael Chao, Morikatsu Wada, et al.. (2010). The use of PET in assessing tumor response after neoadjuvant chemoradiation for rectal cancer. Radiotherapy and Oncology. 97(2). 205–211. 19 indexed citations
4.
Feigen, M., et al.. (2009). Prognostic Value of F-18-FDG PET/CT in Patients with Malignant Pleural Mesothelioma. Molecular Imaging and Biology. 11(6). 2 indexed citations
5.
Ghanem, Mazen A., Rebecca Herbertson, Salvatore U. Berlangieri, et al.. (2009). Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma. Molecular Imaging and Biology. 11(6). 473–479. 24 indexed citations
6.
Nguyen, Brandon, Daryl Lim Joon, Vincent Khoo, et al.. (2008). Assessing the impact of FDG-PET in the management of anal cancer. Radiotherapy and Oncology. 87(3). 376–382. 81 indexed citations
7.
Ball, David, Bryan Burmeister, Paul Mitchell, et al.. (2007). P2-162: Phase I trial of gefitinib in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non small cell lung cancer (“CRITICAL”). Journal of Thoracic Oncology. 2(8). S633–S634. 10 indexed citations
8.
Rischin, Danny, Bryan Burmeister, Paul Mitchell, et al.. (2004). Phase I trial of gefitinib (ZD1839) in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non-small cell lung cancer. Journal of Clinical Oncology. 22(14_suppl). 7077–7077. 7 indexed citations
9.
Feigen, M., et al.. (2003). Impact of oedema on implant geometry and dosimetry for temporary high dose rate brachytherapy of the prostate. Australasian Radiology. 47(2). 172–176. 15 indexed citations
10.
Feigen, M., et al.. (1999). Leiomyosarcoma of the rectum: What role does adjuvant therapy play?. Australasian Radiology. 43(2). 262–265. 2 indexed citations
11.
Feigen, M. & Paul Kitchen. (1999). Internal mammary node relapse following breast conservation: a case for reirradiation. The Breast. 8(5). 291–294. 2 indexed citations
12.
13.
Feigen, M.. (1997). Should Cancer Survivors Fear Radiation‐Induced Sarcomas?. Sarcoma. 1(2). 113–114. 3 indexed citations
14.
Feigen, M.. (1997). Should Cancer Survivors Fear Radiation‐Induced Sarcomas?. Sarcoma. 1(1). 5–15. 16 indexed citations
15.
Feigen, M., et al.. (1988). The value of lymphoscintigraphy, lymphangiography and computer tomography scanning in the preoperative assessment of lymph nodes involved by pelvic malignant conditions. International Journal of Gynecology & Obstetrics. 27(2). 308–308. 16 indexed citations
16.
Feigen, M., B. Cummings, N.V. Hawkins, et al.. (1988). Low dose postoperative adjuvant radiation therapy for rectal cancer is ineffective. Radiotherapy and Oncology. 13(3). 181–186. 6 indexed citations
17.
O'Rourke, Ian C., David C. Johnson, K. W. Tiver, et al.. (1988). Management of oesophageal cancer at Westmead Hospital from 1979–1985. The Medical Journal of Australia. 148(9). 450–456. 9 indexed citations
18.
Feigen, M.. (1986). Ovarian Cancer: A Comparison of Two Techniques for Postoperative Whole Abdominal Radiotherapy. Australasian Radiology. 30(2). 103–108. 2 indexed citations
19.
Feigen, M.. (1984). FATAL VENO‐OCCLUSIVE DISEASE OF THE LIVER ASSOCIATED WITH HERBAL TEA CONSUMPTION AND RADIATION. Australian and New Zealand Journal of Medicine. 14(1). 61–62. 9 indexed citations
20.
Feigen, M., et al.. (1983). Radiation hepatitis following moving strip radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 9(3). 397–400. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.T. Porter Breakdown of academic impact, for papers by Lawrence R. Coia Breakdown of academic impact, for papers by Steve Kelly Breakdown of academic impact, for papers by Kovač Breakdown of academic impact, for papers by A. Rahn Breakdown of academic impact, for papers by Irina Rachinsky Breakdown of academic impact, for papers by Ruth Peter Breakdown of academic impact, for papers by Adrian Wong Breakdown of academic impact, for papers by Justin Rineer Breakdown of academic impact, for papers by Hendrik Dapper
Rankless by CCL
2026